Company / Return on Assets (ROA)
Tvardi Therapeutics, Inc. Return on Assets (ROA) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-195.0%
FY2024
5-year range
-195.0% / 4.6%
FY2020-FY2024
Trend
-177.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -195.0% in FY2024 to 4.6% in FY2022.
Based on SEC 10-K filings.
-195.0% in FY2024 with a 5-year CAGR of -170.1%.
Declined from 4.6% to -195.0% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -152.0pp
- 5-Year Change
- -170.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on assets (roa) decreased 177.5% year-over-year.
- Peak return on assets (roa) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -195.0% | -177.5% |
| FY2023 | -70.3% | -1624.5% |
| FY2022 | 4.6% | +110.7% |
| FY2021 | -43.1% | -57.7% |
| FY2020 | -27.3% | -9.4% |
| FY2019 | -24.9% | +16.9% |
| FY2018 | -30.0% | -18.0% |
| FY2017 | -25.4% | +8.5% |
| FY2016 | -27.8% | -678.7% |
| FY2015 | -3.6% | +68.2% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026